ERCC3 and neoplasm: Triptolide can suppress global transcription by targeting XPB, a subunit of the basal transcription and repair factor II H (TFIIH), and inhibiting the activity of RNA polymerase-II (RNAPII) in tumor cells (Titov et al., 2011).